Quizar 17.7 MG (Quizartinib) Tablets
Introduction Quizar 17.7 mg (Quizartinib) is a highly potent, second-generation, selective small-molecule inhibitor of the Fms-like tyrosine kinase 3 (FLT3) receptor. Manufactured by Everest Pharmaceuticals Ltd. and supplied globally by Onco Solution, Quizar is an advanced targeted therapy specifically for patients with Acute Myeloid Leukemia (AML). It is primarily used to treat adult patients with […]
Lazerib 80 MG (Lazertinib) Tablets
Introduction Lazerib 80 mg (Lazertinib) is a cutting-edge, third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). Manufactured by Everest Pharmaceuticals Ltd. and supplied globally by Onco Solution, this medication is a breakthrough for patients with non-small cell lung cancer (NSCLC). Lazerib is specifically designed to target both the common EGFR mutations and the […]
Repotrex 40 MG (Repotrectinib) Capsules
Introduction Repotrex 40 mg (Repotrectinib) is a next-generation, potent tyrosine kinase inhibitor (TKI) designed for precision oncology. Manufactured by Everest Pharmaceuticals Ltd. and supplied globally by Onco Solution, Repotrex is specifically engineered to target ROS1 and NTRK gene fusions. This medication is a life-saving therapy for patients with locally advanced or metastatic non-small cell lung […]
Binixen 15 MG (Binimetinib) Tablets
Introduction Binixen 15 mg (Binimetinib) is a potent, targeted oncology medication categorized as a MEK inhibitor. Manufactured by Everest Pharmaceuticals Ltd. and supplied globally by Onco Solution, this drug is a breakthrough in precision medicine. Binixen is specifically designed to treat cancers driven by the BRAF V600 mutation, including advanced melanoma and non-small cell lung […]
Revlixen 10 mg (Lenalidomide) Capsule
Introduction Revlixen 10 mg Capsule contains Lenalidomide, an immunomodulatory drug primarily used in the treatment of various hematological cancers. It is known for its potent anti-cancer, antiangiogenic, and immunomodulatory effects. Revlixen is manufactured by Everest Pharmaceuticals Ltd and is supplied globally by Onco Solution — your trusted oncology medicine partner. Key Benefits Indications Revlixen 10 […]
Liposem 2 MG (Saroglitazar Magnesium) Tablets
Introduction Liposem 2 mg (Saroglitazar Magnesium) Tablet is a pioneering dual peroxisome proliferator-activated receptor (PPAR) agonist designed to manage diabetic dyslipidemia and hypertriglyceridemia in patients with Type 2 diabetes mellitus inadequately controlled by statins. Manufactured by Everest Pharmaceuticals Ltd., a WHO-GMP-certified leader in metabolic disorder therapies, and supplied globally by Onco Solution, Liposem 2 mg (Saroglitazar Magnesium) Tablet addresses both lipid […]
Ventoxen 100 MG (Venetoclax) Tablets
Introduction to Ventoxen 100 MG: A New Horizon in Oncology Care Ventoxen 100 mg, a groundbreaking development by Everest Pharmaceutical Ltd., marks a pivotal advancement in the field of oncology, particularly for patients with hematologic malignancies. This innovative medication, centered around the active ingredient Venetoclax, emerges as a beacon of hope in cancer treatment. Supplier […]
Gilternib 40 MG (Gilteritinib) Tablets
Introduction: Gilternib 40 mg, infused with Selpercatinib and developed by Everest Pharmaceutical Ltd., heralds a significant milestone in precision oncology. This novel medication delivers targeted therapy to patients with specific genetic mutations, offering renewed hope and substantially improved outcomes for those battling advanced cancer forms. Description and Usage: Gilternib 40 mg incorporates Selpercatinib, a selective […]
Ivosenib 250 MG (Ivosidenib) Tablets
Introduction to Ivosenib 250 MG: Targeting IDH1 Mutations in Cancer Ivosenib 250 belongs to a class of medications known as IDH1 inhibitors. Mutations in the isocitrate dehydrogenase 1 (IDH1) gene are prevalent in various cancers, including acute myeloid leukemia (AML) and gliomas. These mutations trigger the production of oncometabolite 2-hydroxyglutarate (2-HG), fostering tumorigenesis and disease […]
Moboxen 40 MG (Mobocertinib) Capsules
Introduction to Moboxen 40 mg Moboxen 40 mg, crafted by Everest Pharmaceutical Ltd., represents a groundbreaking advancement in the field of precision oncology. Infused with the active ingredient Mobocertinib, this medication is specifically designed to target genetic mutations, providing new hope and significantly improved treatment outcomes for patients battling specific types of cancer. Description and […]
Selinex 20 MG (Selinexor) Tablets
Introduction: Selinex 20 mg, featuring Selinexor as its key component and crafted by Everest Pharmaceutical Ltd., emerges as a pivotal development in oncology. This medication embodies a new phase in cancer therapy, offering targeted treatment for patients with specific cancer types, fostering hope, and significantly improving their treatment journey. Description and Usage: Selinex 20 mg […]
Tivoxen 1.34 MG (Tivozanib) Capsule
Introduction to Tivoxen 1.34 mg Tivoxen 1.34 mg, featuring Tivozanib as its active ingredient and developed by Everest Pharmaceutical Ltd., represents a transformative breakthrough in the treatment of oncology. This medication delivers targeted therapy for patients with specific cancer types, ushering in renewed hope and significantly improved treatment outcomes. Description and Usage of Tivoxen Tivoxen […]
Trifluxen 15 MG +6.14 MG (Trifluridine and Tipircil) Tablets
Introduction of Trifluxen 15 mg +6.14 mg Trifluxen, encompassing 15 mg of Trifluridine and 6.14 mg of Tipiracil and produced by Everest Pharmaceutical Ltd., introduces a significant breakthrough in the field of oncology therapeutics. It offers a beacon of hope for patients grappling with specific cancer types, heralding a new era of improved outcomes and […]
Ventoxen 10 MG (Venetoclax) Tablets
Introduction: In the realm of modern oncology, Ventoxen 10 mg, imbued with the active compound Venetoclax, emerges as a landmark achievement by Everest Pharmaceutical Ltd., heralding a new dawn in cancer treatment. This medicine is specifically engineered for patients contending with hematological malignancies, illuminating a path of hope and innovation. Onco Solution, by bridging global […]
Alkixen 250 mg (Crizotinib) Capsules
Introduction: Alkixen 250 mg, containing Crizotinib and manufactured by Everest Pharmaceuticals Ltd., stands at the forefront of cancer treatment innovation. This medication represents a paradigm shift in the management of certain types of cancer, offering new hope and improved outcomes for patients worldwide. Description and Usage: Alkixen 250 mg is formulated with Crizotinib, a potent […]
Alpesib 150 MG (Alpelisib) Tablets
Introduction of Alpesib 150 mg: Alpesib 150 mg, infused with Alpelisib and developed by Everest Pharmaceuticals Ltd., marks a transformative advancement in precision oncology. This innovative medication provides targeted therapy for patients with specific genetic mutations, revolutionizing the treatment landscape and offering improved outcomes for individuals battling advanced malignancies. Description and Usage: Alpesib 150 mg […]
Ascimib 40 mg (Asciminib) Tablets
Introduction to Ascimib 40 mg (Asciminib): Abeclib 150 mg, featuring Abemaciclib and produced by Eskayef Pharmaceuticals Ltd., emerges as an innovative therapy in oncology. This medication ushers in a new era of cancer treatment, offering hope and enhanced outcomes for patients afflicted with various cancer types. Description and Usage Abeclib 150 mg incorporates abemaciclib, a […]
Enasinib 50 mg (Enasidenib) Tablets
Introduction: Enasinib 50 represents a groundbreaking advancement in cancer therapy, specifically tailored for patients with hematologic malignancies. Manufactured by Everest Pharmaceutical Ltd., this medication embodies the pinnacle of precision medicine, offering targeted treatment for individuals with IDH2 mutations. Supported by Onco Solution, a global leader in oncology medicine supply and information dissemination, Enasinib 50 mg […]
Diacer Plus 750 MG+50 MG (Diacerein+ Glucosamine Sulphate) Tablets
Introduction of Diacer Plus 750 mg+50 mg In the evolving realm of healthcare, Diacer Plus emerges as a beacon of hope for individuals grappling with the complexities of joint health. Developed by Beacon Pharmaceuticals Ltd. and globally distributed by Onco Solution, Diacer marries the therapeutic prowess of Diacerein and Glucosamine Sulphate, setting new benchmarks in […]
Niranib 100 mg (Niraparib) Capsules
Introduction: In the dynamic realm of oncology, where each advancement marks a stride towards more effective and personalized treatments, Niranib 100 mg emerges as a beacon of hope. Manufactured by Everest Pharmaceutical Ltd. and globally supplied by Onco Solution, this medication encapsulates the essence of precision medicine, specifically designed to navigate the complexities of certain […]